|
Sign In to gain access to subscriptions and/or personal tools.
|
In Vivo Crypt Surface Hyperproliferation Is Decreased by Butyrate and Increased by Deoxycholate in Normal Rat Colon: Associated In Vivo Effects on c-Fos and c-Jun Expression
Omaida C. Velázquez, MD
Harrison Department of Surgical Research, University of Pennsylvania Medical Center, Philadelphia, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia
Dongying Zhou, BA
Harrison Department of Surgical Research, University of Pennsylvania Medical Center, Philadelphia
Renée W. Seto, BA
Harrison Department of Surgical Research, University of Pennsylvania Medical Center, Philadelphia
Abdul Jabbar, MD
Harrison Department of Surgical Research, University of Pennsylvania Medical Center, Philadelphia
Julie Choi
Harrison Department of Surgical Research, University of Pennsylvania Medical Center, Philadelphia
Howard M. Lederer, MD
Harrison Department of Surgical Research, University of Pennsylvania Medical Center, Philadelphia
John L. Rombeau, MD
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia
Background: Studies on colon carcinogenesis suggest that the short-chain fatty acid butyrate may be protective, whereas the secondary bile acid deoxycholate may promote tumor development. Crypt surface hyperproliferation is regarded as a biomarker of colon cancer risk and can be modulated in vitro by the differentiation inducer butyrate and the tumor promoter deoxycholate. We hypothesized that butyrate decreases and deoxycholate increases crypt surface proliferation in vivo and that these effects are mediated by changes in the expression of the protooncogenes c-Fos and c-Jun, which are known to regulate proliferation and differentiation. Methods: Twenty-five adult Sprague-Dawley rats underwent colonic isolation and 24-hour intraluminal instillation of 10 mmol/L sodium chloride, 10 mmol/ L sodium butyrate, or 10 mmol/L sodium deoxycholate. Proliferation of the whole crypt and five crypt compartments from base to surface was assessed by proliferating cell nuclear antigen immunohistochemistry. The  h value, an index of "premalignant" hyperproliferation, was calculated as the ratio of labeled cells in the two surface compartments divided by the labeled cells in the entire crypt. Expression of c-Fos and c-Jun was evaluated by Western blot. Results: Crypt surface proliferation and the h value were significantly decreased by butyrate and increased by deoxycholate. Butyrate increased colonic expression of c-Jun, whereas deoxycholate significantly induced c-Fos. Conclusions: The in vivo effects on surface proliferation are consistent with a potential tumor-promoting role for butyrate and a promotive role for deoxycholate in colon carcinogenesis. The concurrently observed effects on colonic c-Jun and c-Fos expression represent a novel finding and suggest that direct or indirect modulation of protooncogene expression may be the mechanism by which these dietary byproducts regulate proliferation in vivo. (Journal of Parenteral and Enteral Nutrition 20:243-250, 1996)
Journal of Parenteral and Enteral Nutrition, Vol. 20, No. 4,
243-250 (1996)
DOI: 10.1177/0148607196020004243
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
C. L. Kien, R. Blauwiekel, J. Y. Bunn, T. L. Jetton, W. L. Frankel, and J. J. Holst
Cecal Infusion of Butyrate Increases Intestinal Cell Proliferation in Piglets
J. Nutr.,
April 1, 2007;
137(4):
916 - 922.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Kien, M. Schmitz-Brown, T. Solley, D. Sun, and W. L. Frankel
Increased Colonic Luminal Synthesis of Butyric Acid Is Associated with Lowered Colonic Cell Proliferation in Piglets
J. Nutr.,
January 1, 2006;
136(1):
64 - 69.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Domon-Dell, Q Wang, S Kim, M Kedinger, B M Evers, and J-N Freund
Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells
Gut,
April 1, 2002;
50(4):
525 - 529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. A. Weaver, C. T. Tangel, J. A. Krause, M. M. Parfitt, J. J. Stragand, P. L. Jenkins, T. A. Erb, R. H. Davidson, H. D. Alpern, W. B. Guiney Jr., et al.
Biomarkers of Human Colonic Cell Growth Are Influenced Differently by a History of Colonic Neoplasia and the Consumption of Acarbose
J. Nutr.,
November 1, 2000;
130(11):
2718 - 2725.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. E. Crew, D. J.E. Elder, and C. Paraskeva
A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate
Carcinogenesis,
January 1, 2000;
21(1):
69 - 77.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. W. Compher, W. L. Frankel, J. Tazelaar, J. A. Lawson, S. McKinney, S. Segall, B. P. Kinosian, N. N. Williams, and J. L. Rombeau
Wheat Bran Decreases Aberrant Crypt Foci, Preserves Normal Proliferation, and Increases Intraluminal Butyrate Levels in Experimental Colon Cancer
JPEN J Parenter Enteral Nutr,
September 1, 1999;
23(5):
269 - 278.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Klein, D. H. Alters, R. J. Grand, M. S. Levin, H. C. Lin, C. M. Mansbach, C. Burant, P. Reeds, and J. L. Rombeau
Advances in Nutrition and Gastroenterology: Summary of the 1997 A.S.P.E.N. Research Workshop
JPEN J Parenter Enteral Nutr,
January 1, 1998;
22(1):
3 - 13.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. M. Napolitano
Dose-Response Effect of Butyrate
JPEN J Parenter Enteral Nutr,
May 1, 1997;
21(3):
177 - 177.
[PDF]
|
|
|
|
|
|
|
K. A. Tappenden, A. B.R. Thomson, G. E. Wild, and M. I. McBurney
Short-Chain Fatty Acids Increase Proglucagon and Ornithine Decarboxylase Messenger RNAs After Intestinal Resection in Rats
JPEN J Parenter Enteral Nutr,
September 1, 1996;
20(5):
357 - 362.
[Abstract]
[PDF]
|
|
|
|
|
